Aortic valve hemodynamic characteristics after the Ozaki procedure according to echocardiography: a multicenter retrospective study

Aim. To evaluate the aortic valve (AV) hemodynamic characteristics after the Ozaki procedure according to echocardiography.

Material and methods. The retrospective multicenter study included 277 patients with AV defects who were operated on from January 2017 to June 2022 in five centers in Russia. After the Ozaki procedure, the following endpoints were assessed: immediate echocardiographic results (peak AV gradient, mean AV gradient, AV effective orifice area, aortic regurgitation grade), mid-term clinical (three-year survival rate, three-year freedom from reoperation, three-year freedom from grade ≤2 aortic regurgitation) and echocardiographic results (peak and mean AV gradient, AV effective orifice area, aortic regurgitation grade, AV calcification severity). The median follow-up period was 23 (13-32) months. The mean echocardiography follow-up period was 21±10 months.

Results. During the treatment, a decrease in the peak AV gradient was observed from 74±30 mm Hg before surgery up to 12 (8-16) mm Hg one week after surgery, which remained in the mid-term period — 12 (9-15) mm Hg. There was also a decrease in the mean gradient from 40 (27-53) mm Hg before surgery up to 6 (4-8) mm Hg one week after surgery. By the mid-term period, the mean gradient was 6 (4-8) mm Hg. The AV effective orifice area increased from 1 (1-1) cm² to 2 (2-2) cm² in the mid-term follow-up period. Three-year survival rate was 90,2%, freedom from reoperation was 95%, freedom from grade ³2 aortic regurgitation was 88%, and no patient had AV calcification.

Conclusion. The Ozaki procedure in patients with AV defects has good immediate and mid-term hemodynamic parameters according to echocardiography. However, there remains a need for large randomized controlled trials comparing Ozaki procedure with biological AV replacement.

1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a populationbased study. Lancet. 2006;368:1005-11.

2. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561-632. doi:10.1093/eurheartj/ehab395.

3. Ozaki S, Kawase I, Yamashita H, et al. Aortic valve reconstruction using self-developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc. Thorac. Surg. 2011;12:550-3. doi:10.1510/icvts.2010.253682.

4. Ozaki S, Kawase I, Yamashita H, et al. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2018; 155:2379-87. doi:10.1016/j.jtcvs.2018.01.087.

5. Ngo HT, Nguyen TT, Nguyen HC, et al. Bicuspid reconstruction surgery in a patient suffering from aortic valve infective endocarditis with annular abscess using Ozaki's procedure: A case report. Int J Surg Case Rep. 2020;76:266-9. doi:10.1016/j.ijscr.2020.09.197.

6. Amabile A, Krane M, Dufendach K, et al. Standardized Aortic Valve Neocuspidization for Treatment of Aortic Valve Diseases. Ann Thorac Surg. 2022;114(4);1108-17. doi:10.1016/j.athoracsur.2022.03.067.

7. Chernov II, Enginoev ST, Komarov RN, et al. Short-term outcomes of Ozaki procedure: a multicenter study. Russian Journal of Cardiology. 2020;25(S4):4157. (In Russ.) doi:10.15829/1560-4071-2020-4157.

8. Lancellotti P, Pibarot P, Chambers J, et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian. Eur Hear J — Cardiovasc Imaging. 2016;17:589-90. doi:10.1093/ehjci/jew025.

9. Sá MPBO, Perazzo ÁM, Zhigalov K, et al. Aortic valve neocuspidization with glutaraldehydetreated autologous pericardium (Ozaki procedure) — a promising surgical technique. Brazilian J Cardiovasc Surg. 2019;34:610-4. doi:10.21470/1678-9741-2019-0304.

10. Bjoerk VP, Hultquist G. Teflon and Pericardial J aortic valve prostheses. J Thorac Cardiovasc Surg. 1964;47:693-701.

11. Iida Y, Sawa S, Fujii S, Shimizu H.Aortic valve neocuspidization in patients under 65 years old. Gen Thorac Cardiovasc Surg. 2020;68:780-4. doi:10.1007/s11748-020-01302-9.

12. Koechlin L, Schurr U, Miazza J, et al. Echocardiographic and Clinical Follow-up After Aortic Valve Neocuspidization Using Autologous Pericardium. World J Surg. 2020;44:3175-81. doi:10.1007/s00268-020-05588-x.

13. Krane M, Boehm J, Prinzing A, et al. Excellent Hemodynamic Performance After Aortic Valve Neocuspidization Using Autologous Pericardium. Ann Thorac Surg. 2021;111:126- 33. doi:10.1016/j.athoracsur.2020.04.108.

14. Benedetto U, Sinha S, Dimagli A, et al. Aortic valve neocuspidization with autologous pericardium in adult patients: UK experience and meta-analytic comparison with other aortic valve substitutes. Eur J Cardio-Thoracic Surg. 2021;60(1):34-46. doi:10.1093/ejcts/ezaa472.

15. Pirola S, Mastroiacovo G, Arlati FG, et al. Single Center Five Years' Experience of Ozaki Procedure: Midterm Follow-up. Ann Thorac Surg. 2021;111:1937-43. doi:10.1016/j.athoracsur.2020.08.039.

16. Ngo HT, Nguyen HC, Nguyen TT, et al. Reconstruction of aortic valve by autologous pericardium (Ozaki's procedure): Single center experience in Vietnam. Asian Cardiovasc Thorac Ann. 2021;29:394-9. doi:10.1177/0218492320981468.

17. Khatchatourov G, van Steenberghe M, Goy D, et al. Short-term outcomes of aortic valve neocuspidization for various aortic valve diseases. JTCVS Open. 2021;8:193-202. doi:10.1016/j.xjon.2021.08.027.

18. Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92:1022-9. doi:10.1136/hrt.2005.067363.

19. Rayol S da C, Sá MPBO, Cavalcanti LRP, et al. Prosthesis-patient mismatch after surgical aortic valve replacement: Neither uncommon nor harmless. Brazilian J Cardiovasc Surg. 2019;34:361-5. doi:10.21470/1678-9741-2019-0008.

20. Akiyama S, Iida Y, Shimura K, Fujii S, et al. Midterm outcome of aortic valve neocuspidization for aortic valve stenosis with small annulus. Gen Thorac Cardiovasc Surg. 2020;68:762-7. doi:10.1007/s11748-020-01299-1.

21. Sá MP, Chernov I, Marchenko A, et al. Aortic Valve Neocuspidization (Ozaki Procedure) in Patients with Small Aortic Annulus (≤21mm): A Multicenter Study. Struct Hear. 2020;4(5):413-9. doi:10.1080/24748706.2020.1792595.